Abstract: There is increasing impetus to use pharmaceutical interventions, ie, ranibizumab or bevacizumab, for the treatment of particular macular diseases. This paper describes the evidence and decision-making of the National List of Essential Medicines Committee that recently announced the inclusi

With countries progressing towards high COVID-19 vaccination rates, strategies for border reopening are required. This study focuses on Thailand and Singapore, two countries that share significant tourism visitation, to illustrate a framework for optimizing COVID-19 testing and quarantine policies f

Dr. Nishanta Sharma is a quantitative researcher at HITAP Thailand, currently leading a project that assesses the environmental and economic impacts of low-value healthcare services using input-output analysis, as well as exploring the nexus between climate and epidemiology. He holds a PhD in Development and Sustainability from the Asian Institute

Management of advanced prostate cancer, particularly in cases of metastatic castration-resistant prostate cancer (mCRPC), typically involves first-line treatment with the chemotherapeutic agent docetaxel. Nevertheless, disease progression following docetaxel therapy remains a major challenge, as there are currently no therapeutic options listed in

Together with the Mahidol Oxford Tropical Medicine Research Unit (MORU), HITAP has been engaged in assisting with building technical capacity for HTA and more broadly, evidence-informed decisions for health care in Laos since 2019. Towards this objective, HITAP hosted researchers from University of Health Sciences (UHS) and Lao-Oxford-Mahosot Hospi

With Universal Health Coverage (UHC) high on the global health agenda, governments of many low- and middle-income countries (LMICs) have pledged to increase health investments in the scale-up of essential health services to meet the needs of their people. This has led to the recognition of hea

In the Philippines, use of HTA is not completely new; there have been prior efforts to institutionalize a fair and systematic process of generating policy-relevant evidence to inform coverage of health services, such as listing of drugs in the national formulary and new benefits in the national soci

Abstract India’s rapid economic growth has been accompanied by slower improvements in population health. Given the need to reconcile the ambitious goal of achieving Universal Coverage with limited resources, a robust priority-setting mechanism is required to ensure that the right trade-offs arema

Global health is defined as health issues that transcend national boundaries. This notion implies a shared global responsibility for health and is associated with actors beyond country government. In WHO South-East Asia Region (SEAR), the Regional Committee adopted a resolution in 2010 to enco

At the 67th World Health Assembly in Geneva in May 2014, a resolution was adopted on Health intervention and technology assessment in support of universal health coverage. Prof David Haslam, Chair of NICE, representing the UK Mission Geneva, addressed the Assembly during a panel session on the role